Aldose reductase (AKR1B1), the first rate-limiting enzyme involved in the polyol pathway, is linked to the pathogenesis of diabetes-related issues like cataracts, neuropathy, retinopathy and nephropathy (Kato et al., 2009). This evidence concerns the gene AKR1B1 and retinal disorder.